Aktiesnakken — Oktober 2010
-
jeg er negativ overrasket over det dårlige salg. Men på den lange bane tror jeg stadig på stoffet. Men uden flere indikationer godkendt så
-
skal vi gerne have gang i off label salg.
-
Hold nu lige fokus. Det er ikke just den bredeste indikation vi har for Arzerra so far. Det tager tid, også for guldæg.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind